Rheumatoid arthritis Trials in Silkeborg, Denmark
Conditions / Rheumatoid arthritis / Silkeborg, Denmark
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01223911 | A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis | COMPLETED | PHASE2 |
| NCT01283971 | A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor | TERMINATED | PHASE4 |
| NCT03915964 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT00750880 | An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy. | COMPLETED | PHASE3 |
| NCT01491815 | Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction | UNKNOWN | PHASE4 |
| NCT02155894 | Tight Control of Disease Activity Among Patients With RA Based on a Systematic Telemedicine Treatment Strategy | COMPLETED | NA |
| NCT00459706 | Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept | COMPLETED | PHASE3 |
| NCT02944799 | Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis | COMPLETED | PHASE2 |
| NCT01468077 | A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment | COMPLETED | PHASE2 |
| NCT02629159 | A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate | ACTIVE_NOT_RECRUITING | PHASE3 |